Finance

Beta
Lists
4578:TYO
Otsuka Holdings Co Ltd
Â¥10,580.00
0.00%
(0.00) 1D
Jun 5, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4578...
Mkt. cap
5.74T
Avg. vol.
1.22M
Volume
0.00
Dividend
1.32%
Quarterly dividend
Â¥35
Ex-dividend date
Jun 29, 2026
P/E ratio
14.84
52-wk high
Â¥11,910
52-wk low
Â¥6,511
EPS
Â¥713
Shares outstanding
541.85M
No. of employees
38K
Mkt. cap
5.74T
Avg. vol.
1.22M
Volume
0.00
Dividend
1.32%
Quarterly dividend
Â¥35
Ex-dividend date
Jun 29, 2026
P/E ratio
14.84
52-wk high
Â¥11,910
52-wk low
Â¥6,511
EPS
Â¥713
Shares outstanding
541.85M
No. of employees
38K
Analyst outlook
Analyst Ratings
Based on 10 analysts giving stock ratings to 4578 in the past 3 months
Strong Buy
Buy
8
Hold
2
Sell
0
12 month forecast
Based on 10 Wall Street analysts offering 12 month price targets for 4578 in the last 3 months.
Highest
Current ¥10,580.00
Â¥15,700.00 (+48.39%)
Average
Â¥12,757.29 (+20.58%)
Lowest
Â¥10,480.00 (-0.95%)
News stories
From sources across the web
About Otsuka Holdings Co Ltd
CEO-
Employees37.8K
FoundedJul 8, 2008
Headquarters-
SectorPharmaceutical industry
Websiteotsuka.com
Last report
Apr 28, 2026
Fiscal period
Q1 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
630.34B / 594.16B
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
597.93B
637.98B
650.15B
630.34B
Cost of goods sold
168.78B
180.95B
192.74B
174.09B
Cost of revenue
168.78B
180.95B
192.74B
174.09B
Research and development expenses
84.52B
85.74B
104.19B
82.10B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
240.67B
253.75B
279.91B
259.49B
Operating expense
323.33B
287.73B
431.74B
338.04B
Total operating expenses
492.11B
468.69B
624.47B
512.13B
Operating income
105.82B
169.29B
25.68B
118.21B
Other non operating income
-
1.00M
3.94B
-4.00M
EBT including unusual items
112.98B
166.43B
75.26B
130.22B
EBT excluding unusual items
112.22B
180.64B
42.60B
130.51B
Income tax expense
23.08B
40.87B
10.48B
30.93B
Effective tax rate
20.43%
24.56%
13.92%
23.75%
Other operating expenses
-1.86B
-51.76B
47.63B
-3.56B
Net income
88.53B
124.13B
65.49B
98.35B
Net profit margin
14.81%
19.46%
10.07%
15.60%
Earnings per share
-
-
-
-
Interest and investment income
5.01B
2.47B
20.58B
5.98B
Interest expense
-9.73B
-1.34B
-358.00M
-2.04B
Net interest expenses
-4.72B
1.13B
20.23B
3.94B
Depreciation and amortization charges
-
-
-
-
EBITDA
133.84B
197.78B
58.20B
148.58B
Gain or loss from assets sale
531.00M
-
26.43B
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more